TAMBASCO, Nicola
 Distribuzione geografica
Continente #
NA - Nord America 1.937
EU - Europa 1.815
AS - Asia 1.280
SA - Sud America 250
AF - Africa 31
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.320
Nazione #
US - Stati Uniti d'America 1.892
IT - Italia 667
SG - Singapore 572
IE - Irlanda 280
CN - Cina 233
BR - Brasile 211
HK - Hong Kong 197
UA - Ucraina 195
RU - Federazione Russa 145
DE - Germania 126
VN - Vietnam 117
FI - Finlandia 92
SE - Svezia 62
FR - Francia 59
NL - Olanda 58
KR - Corea 55
GB - Regno Unito 54
CA - Canada 27
AR - Argentina 23
IN - India 23
PL - Polonia 15
CH - Svizzera 14
AT - Austria 13
JP - Giappone 13
TR - Turchia 12
BD - Bangladesh 11
IQ - Iraq 11
ZA - Sudafrica 11
BE - Belgio 9
MX - Messico 9
UZ - Uzbekistan 9
ES - Italia 7
LT - Lituania 7
EC - Ecuador 6
CZ - Repubblica Ceca 5
ID - Indonesia 5
MA - Marocco 5
AU - Australia 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
GR - Grecia 3
JM - Giamaica 3
JO - Giordania 3
PY - Paraguay 3
SA - Arabia Saudita 3
BO - Bolivia 2
CI - Costa d'Avorio 2
CO - Colombia 2
DZ - Algeria 2
IL - Israele 2
KE - Kenya 2
KG - Kirghizistan 2
LB - Libano 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
CG - Congo 1
EG - Egitto 1
EU - Europa 1
GT - Guatemala 1
HN - Honduras 1
KH - Cambogia 1
KZ - Kazakistan 1
MD - Moldavia 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
ZW - Zimbabwe 1
Totale 5.320
Città #
Singapore 369
Chandler 314
Dublin 280
Hong Kong 196
San Mateo 146
Ashburn 125
Jacksonville 109
Boardman 106
Perugia 90
Santa Clara 74
Altamura 71
Beijing 68
Medford 61
Princeton 61
Lawrence 57
Milan 57
Munich 55
Seoul 53
Wilmington 48
Moscow 43
Los Angeles 41
Ann Arbor 36
Rome 34
Ho Chi Minh City 30
Dong Ket 29
New York 26
Helsinki 25
Andover 24
Turku 23
São Paulo 20
Des Moines 18
Saint Petersburg 17
Piscataway 16
San Paolo di Civitate 16
The Dalles 16
Bologna 14
Montreal 14
Hanoi 13
Houston 13
Tokyo 13
Brooklyn 12
Genoa 12
London 12
Modena 12
Orem 12
Warsaw 11
Frankfurt am Main 10
Brussels 9
Chennai 9
Denver 9
Falls Church 9
Izmir 9
Johannesburg 9
Padova 9
Redmond 9
Atlanta 8
Columbus 8
Dallas 8
Laion 7
Manchester 7
Mexico City 7
Nuremberg 7
Parma 7
Stockholm 7
Tashkent 7
Woodbridge 7
Chicago 6
Lucca 6
Norwalk 6
Poplar 6
Rio de Janeiro 6
Shanghai 6
Trento 6
Verona 6
West Jordan 6
Baghdad 5
Belo Horizonte 5
Boston 5
Charlotte 5
Formosa 5
Phoenix 5
Redwood City 5
San Francisco 5
Toronto 5
Turin 5
Villongo 5
Amsterdam 4
Can Tho 4
Carlentini 4
Da Nang 4
Erbil 4
Fortaleza 4
Frankfurt Am Main 4
Genova 4
Haiphong 4
Hải Dương 4
Itabira 4
Mumbai 4
Olomouc 4
Padua 4
Totale 3.219
Nome #
The validation of an Italian version of the Freezing of Gait Questionnaire 652
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients 118
Early detection of substantia nigra changes in Parkinson's disease: a magnetization transfer ratio (MTR) study 113
Hippocampal epileptogenesis in autoimmune encephalitis 109
Acute dystonia induced by the combination of midodrine and perphenazine. 108
Cerebrospinal fluid biomarkers in Parkinson disease. 105
A magnetization transfer study of mild and advanced Parkinson's disease. 104
Clinical aspects and management of levodopa-induced dyskinesia. 102
Cerebrospinal fluid lysosomal enzymes and α-synuclein in Parkinson's disease. 99
Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study 98
Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies. 96
Heterozygous X-linked adrenoleukodystrophy-associated myelopathy mimicking primary progressive multiple sclerosis 90
A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies 90
Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson's Disease: Pulsatile versus Continuous Dopaminergic Stimulation 89
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias. 88
A53T in a parkinsonian family: a clinical update of the SNCA phenotypes 87
Efficacy of thrombolytic (rt-PA) therapy in old stroke patients: the Perugia Stroke Unit experience 86
Changes of olfactory tract in Parkinson’s disease: a DTI tractography study 86
Rapid effect of levetiracetam in a case of juvenile myoclonic epilepsy 85
Levodopa-responsive breathing discomfort in Parkinson’s disease patients 85
Magnetization transfer MRI in dementia disorders, Huntington's disease and parkinsonism 84
Prevalence of essential tremor in the territory of Lake Trasimeno, Italy: results of a population-based study 83
Right putamen and age are the most discriminant features to diagnose Parkinson's disease by using 123I-FP-CIT brain SPET data by using an artificial neural network classifier, a classification tree (ClT) 83
T2*-weighted MRI values correlate with motor and cognitive dysfunction in Parkinson's disease 82
Levodopa-induced breathing, cognitive and behavioral changes in Parkinson's disease 81
Young Neurologists and Trainees Stroke Subspecialty Working Group. Educational approach on stroke training in Europe. 80
Brain CT scan in acute ischemic stroke: early signs and functional outcome. 80
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia 80
A novel spinocerebellar ataxia type 15 family with involuntary movements and cognitive decline 79
Shapiro's syndrome: Defining the clinical spectrum of the spontaneous paroxysmal hypothermia syndrome. 78
PEG-J replacement for duodenal levodopa infusion in Parkinson's disease patients: a retrospective study 78
Multimodal use of computed tomography in early acute stroke, part 2. 74
CSF Biomarkers in Parkinson's disease 74
CSF neurochemical profile and cognitive changes in Parkinson's disease with mild cognitive impairment 73
Parkinsonism and cognitive impairment following chronic exposure to potassium cyanide. 73
Entacapone Reduces Cortical Activation in Parkinson's Disease with Wearing-Off: A f-MRI Study 73
Coenzyme Q10, Hyperhomocysteinemia and MTHFR C677T Polymorphism in Levodopa-treated Parkinson's Disease Patients. 71
Levodopa treatment in Parkinson's disease: earlier or later? 71
Levodopa in parkinson’s disease: Current status and future developments 71
Hyperhomocysteinemia recurrence in levodopa-treated Parkinson's disease patients. 70
Magnetization transfer changes of grey and white matter in Parkinson’s disease 68
Occipital pseudoaneurysm as a complication of extension channel placement for DBS in Parkinson's disease. 68
The Brain Dopaminergic System and Hyperthermia: The Neuroleptic Malignant Syndrome and The Parkinsonism-hyperpyrexia Syndrome 68
Validation of the Italian version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale. 68
Multimodal use of computed tomography in early acute stroke 67
Hot water epilepsy and Mccune-Albright syndrome: a case report. 67
Brain CT-scan in acute stroke patients: silent infarcts and relation to outcome. 66
Factors influencing the measurement of lysosomal enzymes activity in human cerebrospinal fluid. 65
Subclinical visuospatial impairment in Parkinson's disease: the role of Basal Ganglia and limbic system. 65
Ictal Epileptic Headache Mimicking Status Migrainosus: EEG and DWI-MRI Findings. 64
Vomiting due to intravenous levetiracetam in a case of Creutzfeldt-Jakob disease. 62
Role of Lysosomal Enzymes in Parkinson’s Disease: Lesson from Gaucher’s Disease 62
Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease. 61
Risk factors of levodopa-induced dyskinesia in Parkinson's disease: results from the PPMI cohort 61
Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap. 60
Long-term follow-up in pediatric patients with paroxysmal hypothermia (Shapiro's syndrome) 60
Multimodal use of computed tomography in early acute stroke, part 1. 59
Complexity of motor sequences and cortical reorganization in Parkinson's disease: a functional MRI study. 55
Prognostic factors in children with PRES and hematologic diseases 54
Hyposmia correlates with axial signs and gait disorder in Parkinson's disease: an Italian Olfactory Identification Test study 51
Movement disorders in 2016: from genes to phenotypes 51
Secondary prevention of cardioembolic stroke: oldest and newest promises. 46
Age-Related Decline in Disengaging Spatial Attention in Physiological Aging 40
Selective basal ganglia vulnerability to energy deprivation: Experimental and clinical evidences 38
Totale 5.454
Categoria #
all - tutte 24.134
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.134


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021188 0 0 0 0 0 17 35 9 47 14 33 33
2021/2022497 7 104 7 7 17 9 10 144 29 23 70 70
2022/20231.004 66 225 15 74 68 101 4 36 374 5 25 11
2023/2024494 29 43 29 9 9 3 94 11 59 21 94 93
2024/20251.153 27 78 39 78 126 78 63 61 209 83 210 101
2025/20261.314 161 179 147 366 331 130 0 0 0 0 0 0
Totale 5.454